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1. Introduction
Recent developments in molecular technology such as gene-expression microarrays and proteomics
have led to a surge in research aimed at discovering markers useful for disease screening or for providing
patient prognosis. We consider a marker to be any measurement that has the potential to signal the
onset or progression of disease. Examples of potential markers include prostate specific antigen (PSA)
as an indicator of prostate cancer, or pulmonary function measures such as forced expiratory volume
(FEV1) as an indicator of functional decline prior to death among cystic fibrosis patients. Longitudinal
marker analysis seeks to evaluate whether changes in a marker process correlate with a key clinical
event time such as disease onset or death. Ideally a marker process would provide definitive and early
information regarding disease onset. However, in practice most biological measurements contain
substantial variability which complicates their use in guiding health care decisions. Characterizing
the accuracy of time-varying markers for disease detection is therefore a critical step in the marker
discovery process.
Retrospective longitudinal studies can be useful in a key phase of marker development (Pepe,
Etzioni, Feng, Potter, Thompson, Thornquist, Winget and Yasui 2001). With this design the ca-
pacity of a marker to detect preclinical disease can be evaluated as a function of time prior to the
clinical occurrence of signs and symptoms. The scientific goal is to identify markers that exhibit
high discriminatory ability at relatively early stages of disease. Traditionally in medical diagnostic
research the receiver operating characteristic (ROC) curve is used to summarize the accuracy or dis-
crimination potential of a marker measurement. (Hanley 1989; Zweig and Campbell 1993). However,
to characterize early disease detection the cross-sectional concepts of sensitivity and specificity that
are typically displayed in an ROC curve need to be extended to incorporate both the time-varying
nature of a marker and the clinical onset time of the disease. In this article we consider new semipara-
metric statistical methods for estimating time-dependent sensitivity, specificity, and ROC curves that
adopt weak distributional assumptions. In addition, we develop the asymptotic distribution theory
that allows inference for either time-dependent sensitivity and specificity, or for time-dependent ROC
curves. Our methods also allow accuracy summaries to depend on covariates, and thus can be used
to evaluate whether the accuracy of a marker varies across patient subgroups.
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In the classic diagnostic testing setting, disease status is represented by a binary variable D i
for subject i. Furthermore, the relationship between Di and a continuous test result Yi for a given
subgroup defined by a covariate vector Zi is displayed through a conditional ROC curve. A conditional
ROC curve displays the full spectrum of values for sensitivity, or the “true positive rate” (TP), P (Y i <
c|Di = 1,Zi), and 1 minus the specificity, or the “false positive rate” (FP), 1− P (Yi ≥ c|Di = 0,Zi)
by considering all possible test threshold values c. Therefore, an ROC curve is a plot of TP versus FP
for c ∈ (−∞,∞). In our definitions for TP and FP we assume that a low marker value is indicative of
disease, but parallel definitions can be adopted when high marker values are associated with disease.
When tests are measured longitudinally, we can define TP and FP as time-dependent functions
TP (s, c|t,Zi) = P [Yi(s) < c|Di(t) = 1;Ti > s,Zi] (1.1)
FP (s, c|t,Zi) = P [Yi(s) < c|Di(t) = 0;Ti > s,Zi]. (1.2)
Here Yi(s) indicates a marker measured at time s, with s ≥ t0, the baseline time, and Di(t) is a
binary variable indicating the disease status of subject i at time t. We recognize that there can be
two useful time-varying “case” definitions to obtain Di(t) = 1 based on the disease time Ti: if we are
interested in the incidence of the disease at time t, then we can define Di(t) = 1 when Ti = t; if we
are interested in the prevalence of the disease by time t, we can define Di(t) = 1 when Ti ≤ t.
In this manuscript we focus on incident ROC curves defined as a plot of [TP I(s, c|t,Z), FP C(s, c|t?,Z)]
for all possible c, where
TP I(s, c|t,Zi) = P [Yi(s) < c|Ti = t;Zi, Ti > s] (1.3)
FP C(s, c|t?,Zi) = P [Yi(s) < c|Ti > t?;Zi, Ti > s] . (1.4)
Here, we use t? in the definition of FP to denote as controls those subjects that do not experience the
disease prior to a fixed follow-up time. This definition is useful when some subjects are thought to
avoid disease and may reasonably be identified as the “long term survivors” characterized by Ti > t
?.
Incident ROC curves are most useful in a retrospective study when the timing of diagnosis for diseased
patients is certain.
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Incorporating the time dimension in ROC analysis has recently been discussed by a number of
authors (Etzioni et al. 1999; Slate and Turnbull 2000; Heagerty, Lumley and Pepe 2000; Cai and
Pepe 2002). Non-parametric methods that characterize accuracy using disease prevalence for the
case definition, Di(t) = 1(Ti ≤ t), is given in Heagerty et al. (2000). Other authors have used
the incident case definition, Di(t) = 1(Ti = t), including Etzioni et al. (1999), Slate and Turnbull
(2000), and Cai and Pepe (2002). There are two general approaches to characterizing accuracy and to
calculating covariate specific ROC curves. First, direct regression approaches for ROC analysis have
been proposed (see Pepe (1998) and Pepe (2003) for reviews). These methods use generalized linear
model concepts to characterize the shape of the ROC curve and to allow covariates to directly impact
accuracy. For longitudinal data Etzioni et al. (1999) illustrate the ROC-GLM approach for evaluating
time-dependent accuracy. Despite recent work that permits flexibility in the direct ROC regression
approach (Cai and Pepe 2002; Li, Tiwari and Wells 1999), the methods have not been extended to
allow covariates to impact the link function, and thus potentially place restrictions on how the shape
of the ROC curve varies with covariates. The semi-parametric methods that we introduce in section
2 permit the shape of the ROC curve to change smoothly with covariates.
A second general approach to estimating covariate specific ROC curves is based on modelling of
the marker distribution conditional on disease status and covariates. Given estimates of the marker
distribution for cases and controls an induced covariate specific ROC can be calculated (Tosteson and
Begg 1988). For longitudinal markers Etzioni et al. (1999) and Slate and Turnbull (2000) discuss a
parametric regression approach that uses linear mixed models to characterize the longitudinal marker
distribution for diseased and non-diseased subjects. In this approach the disease onset time, T i, is
an additional covariate for the cases only. Our proposal is to use smooth semi-parametric regression
quantile methods to model the marker distribution as a function of disease status, covariates, and
disease onset time for the cases. By using flexible regression quantile methods we can relax the
distributional assumptions adopted by previous proposals.
In section 2 we describe the estimation and inference procedures. We outline the asymptotic
distribution theory for the proposed estimators in section 3. We use pulmonary function data from
cystic fibrosis patients to illustrate the method and to compare semi-parametric analysis results to
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parametric results.
2. Semiparametric Regression Quantile Method
2.1 Notation
In many studies subjects are classified either as disease cases or as controls on the basis of the
observed event time. For example, control subjects may be defined as individuals who after t? time
units remain free of disease, while cases are individuals with an observed event time, Ti < t
?. Here we
consider a case-control study setting, where there are nD cases and nD¯ controls among n subjects (i.e.,
n = nD + nD¯). Let Yik be the continuous random variable representing the marker value obtained
from the ith case at the kth visit time sik, with i = 1, . . . , nD, and k = 1, . . . ,Ki. For cases let
ZTik = vec(Ti, sik,Xi), or ZD, denote a vector of covariates associated with Yik, where Xi denotes a
vector of covariates that do not change with time. The total number of observations from the case
population is ND =
∑nD
i=1 Ki. Similarly, denote Yjl as the marker value obtained from the jth control
at the lth visit time sjl, with j = nD + 1, . . . , nD + nD¯, and l = 1, . . . , Lj . For controls let Zjl or
ZD¯ denote a vector of covariates associated with Yjl. Since there are no disease diagnosis times for
controls, ZTjl = vec(sjl,Xj) with Xj as the time-independent covariate vector for the jth control. The
total number of observations for the control group is ND¯ =
∑nD¯
j=1 Lj. We thus have N = ND + ND¯
observations from the two populations.
2.2 Semiparametric Estimation of Regression Quantiles
We propose to use semiparametric regression quantile estimation in order to construct time-dependent
ROC curves. Similar to the methods of Heagerty and Pepe (1999), we characterize the conditional
distribution of [Yik|Zik] as from a location-scale family. Specifically, we represent a case marker value
as
Yik = µD(Zik) + σD(Zik)D(Zik) (2.1)
where µD and σD are the location and scale functions, and the baseline distribution function for D
is
F0,zD() = P [D(Zik) ≤ |Zik]. (2.2)
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We characterize the conditional distribution of the marker measured from the control population
in the same way, with µD¯ and σD¯ representing the location and scale functions, and with the baseline
distribution function denoted
G0,zD¯() = P [D¯(Zjl) ≤ |Zjl]. (2.3)
As in Heagerty and Pepe (1999), for continuous ZD, we model µD(Zik) and σD(Zik) as smooth
functions of Z parametrically using regression splines:
µD(Zik) =
P∑
p=1
βpRp(Zik) (2.4)
logσD(Zik) =
Q∑
q=1
γqSq(Zik) ; (2.5)
where Rp(Zik) and Sq(Zik) are regression spline basis functions. Heagerty and Pepe (1999) used
a quasi-likelihood method for estimation. For example, to estimate βˆp and γˆp (for p = 1, . . . , P )
associated with the case population, we can simultaneously solve the following estimating equations:
nD∑
i=1
Ki∑
k=1
R(Zik)
T [Yik − µD(Zik)]/σ2D(Zik) = 0 (2.6)
nD∑
i=1
Ki∑
k=1
S(Zik)
T {[Yik − µD(Zik)]2 − σ2D(Zik)}/σ2D(Zik) = 0 (2.7)
Estimation for µD¯ and σD¯ follows in a parallel fashion.
Similar to Heagerty and Pepe (1999), the baseline distribution functions F0 and G0 are left
unspecified, and can be estimated empirically based on the standardized residual ikD = D(Zik) =
[Yik − µD(Zik)]/σD(Zik) and jlD¯ = D¯(Zjl) = [Yjl − µD¯(Zjl)]/σD¯(Zjl). If the distributions of the
standardized residuals are independent of covariates, the natural estimators for F0 and G0 are the
empirical distribution functions of the forms
Fˆ0() =
nD∑
i=1
Ki∑
k=1
1
ND
1(ˆikD ≤ ) (2.8)
and
Gˆ0() =
nD¯∑
j=1
Lj∑
l=1
1
ND¯
1(ˆjlD¯ ≤ ), (2.9)
where ˆikD = [Yik − µˆD(Zik)]/σˆD(Zik) and ˆjlD¯ = [Yjl − µˆD¯(Zjl)]/σˆD¯(Zjl). However, more general
methods can be adopted when the baseline distribution functions also vary with covariates ZD or ZD¯.
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In this manuscript we consider the symmetrized nearest neighbor (SNN) estimator (Yang 1981) for
the conditional baseline distribution function, which is defined as a weighted sum
Fˆ0(|Z, an) =
nD∑
i
Ki∑
k
1
W (Z)
wan(Z,Zik)1(ˆikD ≤ ) (2.10)
where W (Z) =
∑
wan(Z,Zik) and an is a bandwidth parameter. A general form for wan can be
assumed with
wan(Z,Zik) = K
[
Hn(Z)−Hn(Zik)
an
]
(2.11)
where K(·) is a continuous and bounded probability kernel on [-1,+1], Hn(·) is the empirical distri-
bution function of Z. An SNN estimator for G0(|Z, an) can be similarly defined. In the following,
we use the notation F0,zD , G0,zD¯ and F0(|Z = zD, an), G0(|Z = zD¯, an) interchangeably.
2.3 Semiparametric Regression-Quantile-Based Estimator of ROC Curves
We now construct an estimator for a time-dependent ROC curve based on the semiparametric regres-
sion quantile estimators. We estimate an ROC curve for a given covariate value Z by first modeling
the marker as functions of covariates ZD for the cases or ZD¯ for controls. By using the semipara-
metric regression quantile methods to model the marker, we can derive a semiparametric estimator
for conditional ROC curves. For convenience, we define a positive test as a marker value less than a
certain threshold, and thus the true positive rate (TP) is defined in terms of the cumulative distri-
bution function F (c) instead of survival function 1− F (c). For any false positive rate p ∈ [0, 1], our
proposed estimator for the ROC curve is
R̂OCz(p) = Fˆ0,zD
[
µˆD¯(zD¯)− µˆD(zD)
σˆD(zD)
+ Gˆ−10,zD¯(p)
σˆD¯(zD¯)
σˆD(zD)
]
≡ Fˆ0,zD
[
αˆ0 + Gˆ
−1
0,zD¯
(p)αˆ1
]
(2.12)
where F0,zD , G0,zD¯ , µD(zD), µD¯(zD¯), σD(zD) and σD¯(zD¯) are defined as in section 2.2. Gˆ
−1
0,zD¯
(p) is
the conditional empirical quantile function, with Gˆ−10,zD¯(p) = inf [ : Gˆ0,zD¯() ≥ p].
3. Asymptotic Distribution Theory for ROC Curve Estimators
In this section we derive the large sample properties of our semiparametric ROC estimators. We first
consider an ROC curve estimator that assumes the baseline distribution functions do not vary with
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covariates Z. We then consider an ROC curve estimator based on SNN estimation of the baseline
distribution function, assuming dependence on covariates. Proofs for the main theorems are detailed
in the appendix.
Hsieh and Turnbull (1996) studied the asymptotic properties of a nonparametric ROC estimator
of the form F [G−1(p)], and a semiparametric ROC estimator where the distributions of F and G are
normal. In the simplest situation where there are no covariates and each subject contributes a single
observation, our estimators reduce to that of Hsieh and Turnbull (1996).
3.1 Baseline Distribution Functions Are Independent of Covariates
When baseline functions are independent of covariates, we use equation 2.8 and equation 2.9 to
estimate the baseline distribution functions F0 and G0.
For asymptotic results we assume the following regularity conditions:
• F0, G0 are continuous with continuous densities f0, g0, respectively.
• The slope of the ROC curve f0[α0 + G−10 (p)α1]/g0[G−10 (p)], is bounded on any interval (a, b),
with 0 < a < b < 1.
• nD/n → λ > 0 as n →∞.
• The number of observations per subject is relatively small with respect to n, the total number
of subjects. i.e., we assume ND/nD → cD and ND¯/nD¯ → cD¯.
Theorem 1 (Consistency of ROC curve estimator) Under the conditions above,
sup
0≤p≤1
|R̂OCz(p)−ROCz(p)| → 0 a.s. as n →∞.
Theorem 2 (Asymptotic normality) Under the conditions above, there exists a probability space
on which one can define sequences of two independent zero-mean Gaussian variables [ U1(p), U2(p), 0 ≤
p ≤ 1 ] respectively such that for 0 < a < b < 1,
√
n[R̂OCz(p)−ROCz(p)] → Ψ(p), a.s. as n →∞ uniformly on [a,b].
with
Ψ(p) =
1
cD
√
λ
U1(p) +
1
cD¯
√
1− λα1
f0[α0 + G
−1
0 (p)α1]
g0[G
−1
0 (p)]
U2(p)
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We specify the forms for U1(p) and U2(p) in the appendix.
3.2 Baseline Distribution Functions Are Smooth Functions of Covariates
In this section we provide asymptotic results for the situation in which baseline functions are smooth
functions of covariates. We use equation (2.10) to estimate the baseline distribution functions F0,z
and use a similar procedure for G0,z.
In addition to the assumptions in section 3.1, we also require the following:
• K(x) is twice continuously differentiable probability kernel which vanishes outside some finite
interval.
• (an)n is a sequence of bandwidths converging to zero, and na3n →∞ as n →∞.
• Z has continuous distribution function H(·).
Theorem 3 (Consistency) Under the conditions above,
sup
0≤p≤1
|R̂OCz(p)−ROCz(p)| → 0 a.s. as n →∞.
Theorem 4 (Asymptotic normality of SSN ROC estimator) Under the conditions above, there
exist a probability space on which one can define sequences of two independent zero-mean Gaussian
random variables [ U ?1 (p), U
?
2 (p), 0 ≤ p ≤ 1 ] such that for 0 < a < b < 1,
√
nan[R̂OCz(p)−ROCz(p)] → Ψ(p), a.s. as n →∞ uniformly on [a,b].
with
Ψ(p) =
1
cD
√
λ
U?1 (p) +
1
cD¯
√
1− λα1
f0,z[α0 + G
−1
0,z(p)α1]
g0,z[G
−1
0,z(p)]
U?2 (p)
We specify the forms for U ?1 (p) and U
?
2 (p) in the appendix.
3.3 Bandwidth Selection
Methods that guide the selection of smoothing parameters facilitate optimal estimation by balancing
bias and variance. In practice one can either employ cross-validation to select a bandwidth that
minimizes a pre-specified loss function, or adopt a data-driven procedure to estimate the asymptot-
ically optimal bandwidth. Ideally if the statistical objective is to estimate conditional ROC curves
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then a criterion focusing directly on key aspects of the ROC curve would be desirable. However,
our methodology is “indirect” in that we first model the marker distribution separately for cases and
controls, and then construct the induced conditional ROC curves. Given our approach, we adopt
an optimal bandwidth selection strategy that is based on the asymptotic distribution of conditional
quantile estimators for the cases and the controls.
For either cases or controls a given percentile p ∈ [0, 1] defines a quantile function p(x) =
F−1(p|x). A theoretical bandwidth that minimizes the asymptotic integrated mean square error
(IMSE) is of the form an = (b/n)
1/5, with
bopt(p) =
(∫
σ2[p(x)|x]
{f [p(x)]|x}2 dx
)
/
(
µ2
∫ {
ω[p(x)|x]
f [p(x)|x]
}2
dx
)
(3.1)
where σ2[p(x)|x] is the variance of the estimator of F [p(x)|x, an], ω[p(x)|x] denotes the second
derivative of the smoothed conditional empirical process evaluated at p(x), and f [p(x)|x, an] is the
conditional density function for ij evaluated at p(x). Ducharme, Gannoun, Guertin and Je´quier
(1995) give a detailed discussion of estimation for the necessary components in equation (3.1) when
analyzing independent data. For dependent data we simply modify the estimate of σ2[p(x)|x] using
a robust variance estimator (see the appendix for details). Since bopt involves unknown quantities
such as σ2[p(x)|x] and ω[p(x)|x], in applications we simply use a plug-in estimator by first choosing
an arbitrary a∗n of order n1/5, and then estimating the terms in bopt(p) based on the preliminary
estimates using a∗n.
Note that bopt(p) is a function of p and therefore may vary for different percentile values. In ROC
analysis we seek to estimate the entire distribution function (all quantiles) rather than focus on a single
percentile value, p. However, not all values for the false positive rate are scientifically important, and
in general interest primarily targets the true positive rate (sensitivity) that corresponds to low false
positive rates (1-specificity). Therefore, for controls we consider bopt(p) calculated for a range of values
such as 0.75 < p < 0.95, and for cases we consider a slightly wider range such as 0.60 < p < 0.95. For
cases and controls, we then evaluate the range of optimal bandwidths and for each group we choose a
single value which is nearly optimal over the percentiles of interest. Further work is warranted toward
developing an optimal bandwidth selection algorithm that is specially tailored for ROC analysis.
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4. Example: Cystic Fibrosis Data
4.1 Study Description
The cystic fibrosis (CF) data we analyze come from the U.S. Cystic Fibrosis Foundation (CFF)
National Patient Registry, a database of patients with CF seen at CFF-accredited care centers. The
registry has been updated annually since 1966 and contains longitudinal measures of participant
health status. Registry information available from 1990-1998 provides 9 years of follow-up on 21,138
patients for a total of N = 171,306 observations. During the follow-up period, 8.52% of the patients
died and thus most of the longitudinal marker information comes from patients who remain alive
through the end of the observation period.
In the subsequent analysis we focus on a standardized pulmonary function measurement known as
FEV1 percent-predicted. This outcome measures the volume of air that a subject expires in 1 second,
and standardizes by dividing the raw volume by the age and gender specific population reference
value. Thus, an FEV1 of 100 indicates that a subject has 100% of the expected lung function for
a healthy child of his/her age. Currently, children are registered for lung transplantation if their
FEV1 drops below a value of 30 (Davis 1997). One clinical question is whether this is an accurate
decision threshold, and whether an age-specific criterion might be warranted. Specifically, what is
the accuracy of the decision guideline? Does this identify most children who would otherwise die in
the near future, and does it capture few of the children who are likely to survive? To examine the
prognostic value of FEV1 at various ages we characterize age-specific sensitivity and specificity. By
estimating conditional quantiles we can compute the threshold value that correctly identifies a given
percent of children who do progress to death (i.e. the sensitivity), and similarly the threshold value
that incorrectly identifies a given percent of children who do not progress to death (i.e. the false
positive rate, or 1-specificity). Furthermore, by creating age-specific ROC curves we can determine
whether controlling the false positive rate at a low value such as 10% leads to adequate sensitivity,
and whether the threshold required to achieve good specificity suggests using a decision cut-off value
that depends on age.
To address the scientific questions we conduct a case-control analysis. A case-control study for
this application has several advantages. First, the sample size of the original CF data is considerable
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and therefore a full cohort analysis would be computationally demanding. Second, the dataset is
well suited for a case-control study since the outcome of interest, death, is rare and the exposure
of interest is commonly available. Therefore, we should be able to estimate an effect comparable to
that obtained from a full cohort analysis without much loss of statistical efficiency. Finally, as our
analysis is essentially retrospective and only requires the measurement time (age) and the time of
death we circumvent the issue of defining an appropriate time origin which would be required for
proper prospective analysis.
In the CF sample we have 21,138 patients, of whom 1,496 died within the follow up period.
For each of the observed cases, we assign two matched controls by selecting subjects who had been
followed for more than 5 years and who are still alive at the end of the study. Furthermore, for the
controls we exclude any observations that were obtained during the last five years before their final
study visit so that all measurements included for analysis were taken at least 5 years before death.
Thus the controls are defined here as those subjects who are ‘known’ to be healthy at the time FEV1
is measured; ‘known’ because death did not occur for at least 5 years. Controls are matched to cases
by age at study entry. The resulting analysis data contain 1,496 cases and 2,992 control subjects with
a total of 15,594 pulmonary function measurements.
The top panel of Figure 1 shows the association between FEV1 and subject age at measurement
time. We use smoothed curves to describe FEV1 as function of age. As expected, the trends are for
FEV1 to decrease with age for both cases and controls. This is consistent with the fact that decline
of pulmonary function with increasing age is a recognized consequence of the disease process. The
data suggest that the distribution of FEV1 is clearly different for cases as compared to controls, and
this discrepancy may also vary with age. The association between FEV1 and time relative to death
for the cases is displayed in the bottom panel of Figure 1. We see that FEV1 tends to be lower at
times close to the time of death compared to times further from death.
In order to estimate ROC curves and to determine whether they vary with age and with time before
death for cases, we fit a series of regression models. For comparison, models are fit both parametrically
using the method described by Etzioni et al. (1999), and using a semi-parametric regression quantile
method introduced in section 2.3. Although we focus on the current FEV1 value as the marker, other
11
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derived outcome measures that are a scalar function of the current and/or past response process could
be candidate markers. For example, the change in FEV1, Y ∗ik(s) = Yik(s)−Yik(s−1), may represent a
marker that reflects failing pulmonary function. However, recent epidemiologic work suggests that the
current level of FEV1 rather than change in FEV1 is predictive of death (Liou, Adler, FitzSimmons,
Cahill, Hibbs and Marshall 2001). Below we briefly summarize the models for FEV1.
4.2 Parametric estimation of ROC curves
For the parametric approach, we use a linear mixed model for FEV1. For cases, we consider two
covariates for the kth measurement of subject i: age at which FEV1 is recorded (sik = ageik), and
years before death (Ti − sik = yearsBDik). Denote Zik = (sik, Ti − sik)T = (ageik, yearsBDik)T ,
the model takes the form
E[FEV 1ik|Zik, bi] = b0,i + b1,i · ageik + βD0 + βD1 · ageik + βD2 · yearsBDik + βD3 · ageik · yearsBDik,
For the lth measurement of control subject j, denote Zjl = (sjl) = (agejl). We assume
E[FEV 1jl|Zjl, bj ] = b0,j + b1,j · agejl + βD¯0 + βD¯1 · agejl .
The models for both cases and controls assume a random intercept and a random slope for age.
Maximum likelihood estimates for the linear mixed models provide estimates for the means (µD,
and µD¯) and standard deviations (σD and σD¯). Assuming normality for both the case and control
populations leads to an induced ROC model:
ROCZ(p) = Φ
[
µD¯(ZD¯)− µD(ZD)
σD(ZD)
+
σD¯(ZD¯)
σD(ZD)
Φ−1(p)
]
,
with Φ denotes the cumulative standard normal distribution. Table 1 summarizes the parameter
estimates for the linear mixed models.
Figure 2 displays the induced ROC curves at various times before death for FEV1 measured at age
10, 15 and 20. At all ages, we see that the discrimination is better when FEV1 is measured at times
closer to death. For example, at age 15, with a threshold of 39.17 for defining “test positive” (90% of
the controls are “test negative”), 60.3% of subjects who subsequently die at age 15 (the same year)
are “test positive”; However, among those who subsequently die at age 20 (thus FEV1 is measured 5
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years prior to death), only 30.6% are “test positive”. Using this approach, there does not appear to
be a trend in accuracy with age (Table 2). For example, if the false positive rate is controlled at 10%
them when FEV1 is measured at the year of death (the time at which FEV1 is the most accurate),
57% of the children at age 10 are identified as “test positive”, whereas for FEV1 measured at age 20,
59% of those patients who died at age 20 were identified as “test positive”.
4.3 Semiparametric Regression Quantile Estimation of ROC curves
Separate models are now considered using the semiparametric regression quantile method to char-
acterize the marker distributions for cases and controls. For controls, we model the mean function
as
µD¯(ZD¯) = β
D¯
0 + (β
D¯)TB(age)
and the logarithm of the standard deviation as
logσD¯(ZD¯) = γ
D¯
0 + (γ
D¯)TB(age)
where B(age) is a natural spline basis with knots at 10 and 20 years. For the baseline distribution G0
we chose either to use Gˆ0(D¯), the empirical distribution function of the standardized residuals, or
use the locally weighted empirical distribution function Gˆ0(D¯|age, an), where we consider distance
based on age.
For cases, we model the mean function as
µD(ZD) = β
D
0 + (β
D)T [B(age) · B(yearBD)]
and the logarithm of the standard deviation as
logσD(Z) = γ
D
0 + (γ
D)T [B(age) + B(yearBD)]
where B(age) is a natural spline basis with knots at 10 and 20, and B(yearBD) is a natural spline
basis with knots at 2 and 4 years. For baseline distribution F0 we chose either to use Fˆ0(D), the
empirical distribution function of the standardized residuals, or use the locally weighted empirical
distribution function, where we consider distance based on either age only, Fˆ0(D|age, an), or years
before death only, Fˆ0(D|yearBD, an). In our application, we use the Epanechnikov kernel K(x) =
13
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3
4(1− x2)I{|x| ≤ 1} and we select a bandwidth such that about 20% of the observations are included
for estimation at each unique value of Z. This bandwidth is selected based on a data-driven optimal
bandwidth selection algorithm described in section 3.3, and the estimated optimal bandwidths do
not appear to vary much when 0.75 ≤ p ≤ 0.95. For example, the bandwidth estimates for the cases
given by (3.1) are b̂opt(0.75) = 0.134 and b̂opt(0.95) = 0.143.
For controls, we observe a trend for the estimated mean FEV1 function µˆD¯ to decrease with
increasing age. The standard deviation function, however, does not appear to vary much between 10 to
30 years of age. We also examine plots (not shown here) of the baseline distribution function Gˆ0(|age),
and the estimated percentiles of FEV1 as function of age based on the semiparametric quasi-likelihood
method: µˆD¯(age)+σˆD¯(age)Gˆ0(D¯|age). Both the baseline distribution and equivalently the estimated
percentiles appear to depend on age.
For cases, we examine the estimated mean µˆD and the estimated standard deviation σˆD as a
function of year before death for various ages (Figure 3). We see that the mean function at age 10 is
generally higher than that at age 20, similar to the trend observed for controls. For each age, FEV1
level appears to increase as the time relative to death increases from 0 to four years, then gradually
levels off. The standard deviation function follows a similar pattern, but to a lesser extent. We also
check plots (Figure 4) that show the baseline distribution function as a function of age, Fˆ0{|age}, and
as a function of years before death, Fˆ0{|yearBD}. For both situations, higher percentiles appear to
vary with covariates more than lower percentiles. This suggests that a variable baseline distribution
estimator may be more appropriate than a constant baseline assumption for these data.
We compare the empirical distribution of the standardized residuals with a standard normal
distribution, for cases, the empirical percentile is generally higher than the Gaussian percentile in
the left part of the distribution (below 30%), but it tends to be lower than the Gaussian percentile
between 30% and 90%. QQ-plot (not shown) also reveals right skewness. This implies that the normal
assumption may not be plausible for these data. In contrast, for controls the empirical percentile is
in good agreement with the Gaussian percentile, and the QQ-plot reveals little skewness.
ROC curves at various times before death for 15 year olds are displayed in Figure 5. We compare
the ROC curves that assume F0 does not depend on covariate (panel (a)), those that assume F0
14
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depends on age (panel (b)), and those that assume F0 depends on the year before death (panel (c)).
Similar to the findings with the parametric method, we observe better discrimination between cases
and controls when FEV1 is measured at times closer to death across all ages and regardless of the
specific assumptions on F0. However, the ROC curves at 0, 1, 3, 5 years before death are considerably
different depending on the assumption about F0: the ROC curves at various times before death are
relatively closer to each other if we use the empirical distribution of the standardized residual to
estimate F0, in contrast to the ROC curves obtained by letting F0 vary with the time relative to
death. This can also be seen from Table 3, which lists the estimated sensitivities when specificity
equals 0.9. For example, at age 15, with an FEV1 value of 41 as the threshold for defining “test
positive”, 90% of the controls (those who lived at least beyond 20 years and are known to be alive
by the end of the study) are “test negative”. When F0 is assumed to be constant, the fraction of
subjects who are test positive are 74%, 66%, 49%, and 36% among those CF patients who die at age
15, 16, 18, and 20, respectively. However, if F0 depends on the time relative to death, then with the
same threshold, the corresponding true positive fractions become 80%, 69%, 50%, and 35%, which
for 0 and 1 year prior to death are meaningfully different from the estimates obtained based on the
other assumptions. Furthermore, comparing Table 3 with Table 2, we see there are also discrepancies
between the estimates from the parametric method and those from the semi-parametric method. In
order to estimate an ROC curve, we need to carefully characterize all components of the distribution,
including the mean, the standard deviation, and the baseline distribution function. Misspecification
of any of the three components may result in biased estimates of sensitivity and specificity.
The next logical step is to chose a model that best describes the baseline distribution. Developing
a formal model selection procedure in the semi-parametric setting appears to be difficult. Instead, we
suggest employing graphical summaries to assess whether the baseline distribution appears to vary
with covariates. For example, we can utilize QQ-plots to compare the distribution of the standardized
residuals across different values of a covariate. In Figure 6, we plot the quantiles of residuals at k
years prior to death against the quantiles of residuals at k + 1, . . . , 8 years prior to death for cases.
Many QQ-plots in the figure appear to be curved, indicating that the baseline distribution may not
be constant over years prior to death. In contrast, when we examine the baseline distribution across
15
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different ranges of age most of the QQ-plots are close to diagonal lines, and this is especially true for
controls. Thus, the assumption that G0 does not depend on age may be plausible for the data from
controls.
We also fit the same models using a Gaussian kernel function instead of the Epanechnikov’s
kernel function to estimate the baseline distributions. The estimated sensitivities are similar to those
in Table 3, indicating that the choice of the kernel function does not have substantial impact on the
estimation.
5. Summary
In this article, we introduce an approach for constructing time-dependent ROC curves that is based
on the semi-parametric regression quantile method for longitudinal data studied by Heagerty and
Pepe (1999). We characterize the reference distribution of a key clinical measurement for healthy and
diseased populations using a location-scale family. Quasi-likelihood methods are used to estimate
conditional mean and standard deviation functions. The empirical distribution, or a weighted empir-
ical distribution is used to characterize the shape of the marker distribion. We detail the asymptotic
theory for ROC estimators under two situations: where the baseline distribution is constant; and
where the baseline distribution is allowed to depend on covariates. For the second case we modify
the theoretical results from the conditional empirical process literature for the independent situation
(Stute 1984; Stute 1986) to account for the repeated measurements. Finally we use CF data to as-
semble a case-control study and build ROC curves that assess how well the distribution of FEV1
for cases at various times prior to death is separated from that of the controls. We compare the
results from our new methodology with that of a parametric method (Etzioni et al. 1999). Our
results indicate that specification of all three features of a distribution: mean; standard deviation;
and baseline function; makes a significant impact on the resulting ROC estimates. Compared with
the parametric approach, our method offers greater flexibility by having separate model choices for
each of the key distributional aspects. For independent data a parametric approach can be made
more flexible by adopting Box-Cox transformation methods for quantile estimation proposed by Cole
and Green (1992). Heagerty and Pepe (1999) discuss use of these methods for longitudinal measure-
ments. However, one of the main limitations of the Box-Cox approach is the necessary correct model
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specification (i.e. normality) for consistency of estimates, while our semiparametric method provides
generally consistent quantile estimates.
In our application, we have used kernel weight functions that require specification of a bandwidth.
Further work is warranted exploring appropriate data-driven optimal bandwidth selection procedures
tailored for ultimate ROC analysis. In addition, although we have detailed the large sample theory
for semiparametric ROC estimators the performance of our theoretical results should be evaluated
in small samples, and perhaps compared with alternative bootstrap inference methods. Finally, a
methodological issue illustrated in the cystic fibrosis analysis is the potential sensitivity of ROC
results to the selection of the baseline distribution model. Although we propose graphical methods
to assess the appropriateness of model assumptions, more formal model comparison methods would
be useful.
17
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Appendix A. Large Sample Properties for Proposed Estimators
A.1 Proof of Theorem 1
Lemma 1 Let Fˆ0() =
∑nD
i=1
∑Ki
k=1
1
ND
1(ˆik ≤ ) as in section 2.2, then
P [sup
x
|Fˆ0(x)− F0(x)| → 0] = 1.
The lemma is a straightforward extension of the Glivenko-Cantelli Theorem to weakly dependent,
identically distributed random variables. We omit the proof here.
Lemma 2 Let Gˆ0() =
∑nD¯
j=1
∑Lj
l=1
1
ND¯
1(ˆjl ≤ ) and Gˆ−10 (p) = inf [ : Gˆ0() ≥ p] as in section 2.2.
P [|Gˆ−10 (p)−G−10 (p)| → 0] = 1.
The lemma can be established the same way as for showing the convergence of quantile for the
independent data (Shorack and Wellner 1986). For additional details regarding lemmas 1 and 2
please see Zheng (2002).
Proof. For αˆ0 and αˆ1 as defined in equation (2.12),
sup
0≤p≤1
|R̂OCz(p)−ROCz(p)|
= sup
0≤p≤1
∣∣∣Fˆ0 [αˆ0 + Gˆ−10 (p)αˆ1]− F0 [αˆ0 + Gˆ−10 (p)αˆ1]+ F0 [αˆ0 + Gˆ−10 (p)αˆ1]− F0 [α0 + G−10 (p)α1]∣∣∣
≤ sup
0≤p≤1
∣∣∣Fˆ0 [αˆ0 + Gˆ−10 (p)αˆ1]− F0 [αˆ0 + Gˆ−10 (p)αˆ1]∣∣∣+ sup
0≤p≤1
∣∣∣F0 [αˆ0 + Gˆ−10 (p)αˆ1]− F0 [α0 + G−10 (p)α1]∣∣∣
= I1 + I2
for I1, since Gˆ
−1
0 (p) → G−1(p) by Lemma 2, αˆ1 → α1, and αˆ0 → α0, then by the Slutsky theorem
αˆ0 + Gˆ
−1
0 (p)αˆ1 → α0 + G−1(p)α1 in probability. Following Lemma 1, we have I1 → 0 in probability.
In addition, I2 → 0 in probability by the continuity of F0. This proves the Theorem. 2
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A.2 Proof of Theorem 2
Proof.
√
n[R̂OCZ(p)−ROCZ(p)]
=
√
n
{
Fˆ0
[
αˆ0 + Gˆ
−1
0 (p)αˆ1
]
− F0
[
αˆ0 + Gˆ
−1
0 (p)αˆ1
]}
+
√
n
{
F0
[
αˆ0 + Gˆ
−1
0 (p)αˆ1
]
− F0
[
α0 + G
−1
0 (p)α1
]}
= W1 + W2,
we first approximate W1 with a sum of i.i.d. terms: W˜1 =
1√
λcD
√
nD
1
nD
∑nD
i ξiD, with
ξiD =
Ki∑
k=1
{
1[ik < α0 + G
−1
0 (p)α1]− F0[α0 + G−10 (p)α1]
}
By applying the Central limit theorem, we have for any 0 < p < 1, W˜1 →D 1√λcD U1(p),where U1(p)
is a zero-mean normal distribution whose variance σ2D can be estimated by σˆ
2
D =
1
nD
∑nD
i ξˆ
2
iD. ξˆ
2
iD
are obtained from ξiD by replacing ik, F0, G
−1
0 (p), α0 and α1 with ˆik, Fˆ0, Gˆ
−1
0 (p), αˆ0 and αˆ1.
For W2, we first take first order Taylor series expansion:
W2 =
√
nD + nD¯f0
[
α0 + G
−1
0 (p)α1
] {
αˆ1
[
Gˆ−10 (p)−G−10 (p)
]
+
[
αˆ0 + αˆ1G
−1
0 (p)− α0 − α1G−10 (p)
]}
+ op(1)
Now,
√
nD¯{Gˆ0[G−10 (p)]−G0[G−10 (p)]} =
√
nD¯
nD¯
ND¯
1
nD¯
∑nD¯
j ξjD¯ is a sum of i.i.d terms, with ξjD¯ =∑Lj
l=1
{
1
[
jl < G
−1
0 (p)
]− p}, again by applying the Central limit theorem, we have for any 0 < p < 1,
√
nD¯{Gˆ0[G−10 (p)]−G0[G−10 (p)]} converge to a zero-mean normal distribution U2a(p) whose variance
can be estimated by σˆ2
D¯
=
∑nD¯
j ξˆ
2
jD¯
. Let h be a mapping such that h(y) = G−10 (y), and h˙
−1 =
g0[G
−1
0 (p)] is continuous. Following Crame´r’s theorem, we have
√
nD¯
[
Gˆ−10 (p)−G−10 (p)
]
→d 1
g0[G
−1
0 (p)]
U2a(p)
In addition, denote VD as the variance-covariance matrix for βD (the parameters for µD) and
γD (the parameters for σD). Similarly, denote VD¯ as the variance-covariance matrix for β D¯ (the
parameters for µD¯) and γ D¯ (the parameters for σD¯), θ = (βD, γD, β D¯, γ D¯), we have
√
n

βˆD − βD
γˆD − γD
βˆ D¯ − β D¯
γˆ D¯ − γ D¯
→d N (0, [ 1λVD 00 11−λVD¯
]
) ≡ N (0,Σ),
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Let g(θ) = α0 + G
−1
0 (p)α1, and let g
′(θ) denote its derivative, by Crame´r’s device, we have
√
nD + nD¯
[
αˆ0 + αˆ1G
−1
0 (p)− α0 − α1G−10 (p)
]→D N (0, g′(θ)Σg′(θ)T ) ≡ U2b(p)
Thus for any 0 < p < 1, we have
W2 →d 1
cD¯
√
1− λα1
f0[α0 + G
−1
0 (p)α1]
g0[G−1(p)]
U2a(p) + f0[α0 + G
−1
0 (p)α1]U2b(p)
≡ α1
cD¯
√
1− λ
f0[α0 + G
−1
0 (p)α1]
g0[G−1(p)]
U2(p)
Since W1 and W2 are independent,
W1 + W2 →d Ψ(p) = 1
cD
√
λ
U1(p) +
α1
cD¯
√
1− λ
f0[α0 + G
−1
0 (p)α1]
g0[G−1(p)]
U2(p)
2.
A.3 Proof of Theorem 3
Without loss of generality, we now assume the covariate vector Z is a scalar in the proof. The following
lemmas, whose proofs are omitted, follow from the results for conditional empirical processes and
conditional quantile processes (Stute 1986).
Lemma 3 Let Fˆ0(|Z = z, an) =
∑nD
i
∑Ki
k
1
W (z)wan(z, Zik)1(ˆik ≤ ),where W (z) =
∑
wan(z, Zik)
with a general form of wan :
wan(z, Zik) = K
[
Hn(z)−Hn(Zik)
an
]
we have
P
[
sup

|Fˆ0(|z, an)− F0(|z, an)| → 0
]
= 1.
Lemma 4 Let Gˆ0(|Z = z, an) =
∑nD¯
j
∑Lj
l
1
W (z)wan(z, Zjl)1(ˆjl ≤ ) and Gˆ−10,z(p) = inf [ : Gˆ0(|Z =
z, an) ≥ p], then
P
[
sup
z
|Gˆ−10,z(p)−G−10,z(p)| → 0
]
= 1.
Proof of Theorem 3.
The theorem is easily shown in view of lemma 3 and lemma 4.
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A.4 Proof of Theorem 4
Lemma 5 Under the assumptions
A. an → 0 such that na3n →∞ and na5n → 0,
B. there exists a distribution function of (Z, ), say, M, with uniform marginals, and
C. sup‖t−s‖<δ |F (t|z) − F (s|z)| = o[(lnδ−1)−1] as δ → 0, uniformly in a neighborhood of z,
we have for F¯0(|Z = z, an) = a−1n
∫
1(u ≤ )K
[
H(z)−H(v)
an
]
M(dv, du),
√
nDan[Fˆ0(|Z = z, an)− F¯0(|Z = z, an)] →d N (0, σ2D)
for µ-almost all  ∈ R, where M is a distributional function of (Z, ) and σ2D can be consistently
estimated by
σˆ2D =
1
nD
nD∑
i=1
Ki∑
k=1
Ki∑
l=1
1
anc2D
{
I(ik ≤ )K
[
Hn(Z)−Hn(Zik)
an
]
I(il ≤ )K
[
Hn(Z)−Hn(Zil)
an
]}
Remarks: The assumptions are the same as for the independent case given by Stute (1986). For
assumption B, Let H denote the distribution function of Z, and L be the distribution function of ,
we have
M(Z, ) = C[H(Z), L()]
i.e., M , a distribution function on [0, 1]2 with uniform marginals, can be obtained by finding a
transformation function C on [H(Z), L()]. Thus we reduce our investigation to some uniform random
function.
Assumption C is satisfied whenever F0 is continuous of some order. It entails the equicontinuity
of F0 in a neighborhood of z.
Proof.
The proof for independent observations is given by Stute (1986). We now extend his results to the
correlated data situation to show that βn =
√
nDan[Fˆ0(|Z = z, an)− F¯0(|Z = z, an)] →d N (0, σ2D).
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Let
Fˆ ∗0 (|Z = z, an) = a−1n
nD∑
i
Ki∑
k
wan(z, Zik)1(ˆik ≤ ).
now, Fˆ ∗0 (|Z = z, an) = Fˆ0(|Z = z, an)(NDan)−1W (Z) ≡ Fˆ0(|Z = z, an)fn(z), and Stute (1986)
shows that (nDan)
1/2[fn(z)− 1] →p 0, and thus under the smoothness assumptions
βn =
√
nDan[Fˆ
∗
0 (|Z = z, an)− F¯0(|Z = z, an)] + op(1) uniformly in .
In what follows we only work with Fˆ ∗0 (|Z = z, an), of which the asymptotic properties are the same
as those of Fˆ0(|Z = z, an).
Let Mn denote the bivariate empirical d.f. of the sample (Z1, 1), · · · , (ZND , ND), we can write
Fˆ ∗0 (|Z = z, an) in the form of Fˆ ∗0 (|Z = z, an) = a−1n
∫
1(u ≤ )K
[
Hn(z)−Hn(v)
an
]
Mn(dv, du). Because
of the heavy dependence of the weights for summands, we can not apply a central limit theorem to
nD dependent r.v.s directly. So the first goal of the proof is to approximate the SNN estimator with
a quantity that is the sum of nD independent random variables. The asymptotic approximation is
essentially the same as the method used when the ′is are independent, details of which were given
by Stute (1984) and Stute (1986). In the following, we only outline the approximation procedure,
omitting further details that can be found in Stute (1984).
Assuming K is twice differentiable, we start by applying Taylor expansion to Fˆ ∗0 (|Z = z, an):
Fˆ ∗0 (|Z = z, an) = a−1n
∫
1(u ≤ )K
[
H(z)−H(v)
an
]
Mn(dv, du)
+ a−2n [Hn(z)−Hn(v) −H(z) + H(v)]
∫
1(u ≤ )K ′
[
Hn(z)−Hn(v)
an
]
Mn(dv, du)
+ a−3n
∫
1(u ≤ )[Hn(z)−Hn(v)−H(z) + H(v)]2K ′′(∆)Mn(dv, du)/2
≡ I1 + I2 + I3,
where ∆ is on the line segment between a−1n [Hn(z) − Hn(v)] and a−1n [H(z) − H(v)]. Follows from
Lemma 1 in Stute (1984), we have (nDan)
1/2I3 →p 0 as nD → ∞. Furthermore, Stute (1984) yields
that (nan)
1/2I2 is asymptotically equivalent to
−n1/2D a−1/2n F0(|Z = z)
∫
K
[
H(z)−H(v)
an
]
n
1/2
D [Hn(dv)−H(dv)].
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thus,
βn =
√
nDana
−1
n
∫
1(u ≤ )K
[
H(z) −H(v)
an
]
Mn(dv, du)
− n1/2D a−1/2n F0(|Z = z)
∫
K
[
H(z)−H(v)
an
]
n
1/2
D [Hn(dv) −H(dv)]
− √nDana−1n
∫
1(u ≤ )K
[
H(z) −H(v)
an
]
M(dv, du)
= (
nD
an
)1/2
∫
[1(u ≤ )− F0(|Z = z)] K
[
H(z) −H(v)
an
]
[Mn(dv, du) −M(dv, du)]
Furthermore, (nDan )
1/2
∫
[1(u ≤ )− F0(|Z = z)] K
[
H(z)−H(v)
an
]
M(dv, du) is asymptotically negligi-
ble. Thus, asymptotically, βn = n
1/2
D
∑nD
i=1 ξi with
ξi =
Ki∑
k=1
ξik =
Ki∑
k=1
∫
1√
an
[1(u ≤ )− F0(|Z = z)] K
[
H(z)−H(v)
an
]
Mik(dv, du)
which is a standardized sum of nD i.i.d random variables. To apply the Central Limit Theorem, we
need to check that E(ξ2i ) < ∞. Now, E(ξ2i ) = E
(∑Ki
k=1
∑Ki
l=1 ξikξil
)
≤ ∑Kik=1∑Kil=1 (Eξ2ikEξ2il)1/2,
with
Eξ2ik = a
−1
n
∫
[1(u ≤ )− F0(|Z = z)]2 K2
[
H(z)−H(v)
an
]
M(dv, du)
= a−1n
∫
E
{
[1(u ≤ )− F0(|Z = z)]2 |Z = v
}
K2
[
H(z)−H(v)
an
]
H(dv)
→ h(z)
∫
K2(s)ds < ∞.
Hence E(ξ2i ) < ∞ since Ki is small relative to n. It then follows from the Central Limit Theorem
that βn →d N (0, σ2D). A consistent estimator for σ2D is σˆ2D = 1nD
∑nD
i=1
∑Ki
k=1
∑Ki
l=1 ξˆik ξˆil.
ξˆik can be obtained by substituting the theoretical terms with their empirical counterparts.
Follows Corollary 2 of Stute (1986), we have for µ-almost all 0 < z < 1, when na5n → 0, and under
the additional assumption that for each  F0(|·) is twice continuously differentiable in a neighborhood
of z,
(nDan)
1/2[Fˆ0(|Z = z, an)− F0(|Z = z, an)] →d N(0, σ2D)
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Remark when we select optimal bandwidth with aoptn , na5n → c, c > 0, the limit process of the
conditional empirical is a noncentered Gaussian process, with some ‘bias’ term of the form
√
c
2
F
′′
(|z)
∫
u2K(u)du
Lemma 6 (Asymptotic normality of the conditional quantile process) Define a conditional
quantile function as
Gˆ−10 (p|z) = inf{ ∈ R : Gˆ0(|z) ≥ p},
which is an estimator for the p quantile of G0(·|z) for 0 < p < 1. for such p, write p = G−10 (p|z).
Under the above assumptions, if g0(p|z) = (∂/∂)G0(|z) > 0 at  = p and F is continuous we have
for almost all z
(nD¯an)
1/2[Gˆ−10 (p|Z = z, an)−G−10 (p|Z = z, an)] →d
1
g0(p|z)N (0, σ
2
D¯)
where
σ2D¯ =
1
nD¯
nD¯∑
j=1
Lj∑
l=1
Lj∑
m
ξjlξjm
with
ξjl =
1√
ancD¯
[1(jl ≤ p)−G0(p|Z = z)] K
[
H(z)−H(zjl)
an
]
We omit the proof here.
Proof of Theorem 4
√
nan[R̂OCz(p)−ROCz(p)]
=
√
nan
{
Fˆ0,z
[
αˆ0 + Gˆ
−1
0,z(p)αˆ1
]
− F0,z
[
αˆ0 + Gˆ
−1
0,z(p)αˆ1
]}
+
√
nan
{
F0,z
[
αˆ0 + Gˆ
−1
0,z(p)αˆ1
]
− F0,z
[
α0 + G
−1
0,z(p)α1
]}
= W1 + W2
Now, by lemma 5, it can be shown that W1 →d 1cD√λU
?
1 (p). Here U
?
1 (p) is a zero-mean normal
distribution with variance σ2D for any 0 < p < 1. A consistent estimator of σ
2
D is
σˆ2D =
1
nD
nD∑
i=1
Ki∑
k=1
Ki∑
l=1
ξˆikξˆil
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ξˆik can be obtained by substituting the theoretical terms with their empirical counterparts, i.e.,
ξˆik =
1√
an
{
1[ˆik ≤ αˆ0 + Gˆ−10 (p)αˆ1]− Fˆ0[αˆ0 + Gˆ−10 (p)αˆ1|Z = z]
}
K
[
Hn(z)−Hn(zik)
an
]
By the fact that an → 0 and lemma 6, it is easy to show that for any 0 < p < 1, we have
W2 →d 1cD¯√1−λα1
f0[α0+G
−1
0
(p)α1 ]
g0,z(p)
U?2 (p), where U
?
2 (p) is a zero-mean normal distribution with variance
σ2
D¯
for any 0 < p < 1. A consistent estimator of σ2
D¯
is
σˆ2D¯ =
1
nD¯
nD¯∑
j=1
Lj∑
l=1
Lj∑
m=1
ξˆjlξˆjm
ξˆjl can be obtained by substituting the theoretical terms with their empirical counterparts.
Since W1 and W2 are independent,
W1 + W2 →d Ψ(p) ≡ 1
cD
√
λ
U?1 (p) +
1
cD¯
√
1− λα1
f0,z[α0 + G
−1
0,z(p)α1]
g0,z(p)
U?2 (p)
2.
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Years before death
FE
V1
1 3 5 7 9
0
50
10
0
15
0
slope= 3.806
Figure 1: (a) FEV1 versus age at measurement for CF patients. Separate lines are fitted for controls,
cases and all patients with smoothing splines. (b)FEV1 versus time relative to death for CF patients.
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Figure 2: ROC curves for FEV1 measured at age 10, 15, and 20 at 0, 1, 3 and 5 years prior to death
using parametric RQ method. Panel(a)-(c) show the ROC curves at different ages. The diagonal line
in each plot is included for reference.
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Figure 3: Mean (top panels) and standard deviation (bottom panels) of FEV1 as a function of years before death for cases at various
ages: the functions are estimated with natural regression splines with knots placed at locations denoted by the vertical tick marks.
Dotted lines are the pointwise 95% confidence intervals.
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Figure 4: (a) Estimated quantiles of F0 based on the kernel estimation method. F0 is allowed to
depend on age.(b) Estimated quantiles of F0 based on the kernel estimation method. F0 is allowed
to depend on years before death.
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(b) Age = 15, F0(Age)
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(c) Age = 15, F0(AgeBD)
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Figure 5: ROC curves for FEV1 measured at age 15 at 0, 1, 3 and 5 years prior to death using
semiparametric RQ method. Panel (a) shows the ROC curves assuming F0 does not depend on
covariate. Panel (b) shows the ROC curves assuming F0 depends on age. Panel (c) shows the ROC
curves assuming F0 depends on years before death. The diagonal line in each plot is included for
reference.
V
http://biostats.bepress.com/uwbiostat/paper220
std.residual at 1  yearsBD
s
t
d
.
r
e
s
i
d
u
a
l
 
a
t
 
2
 
 
y
e
a
r
s
B
D
-2 0 2 4
-
2
0
2
4
std.residual at 1  yearsBD
s
t
d
.
r
e
s
i
d
u
a
l
 
a
t
 
3
 
 
y
e
a
r
s
B
D
-2 0 2 4
-
2
0
2
4
std.residual at 1  yearsBD
s
t
d
.
r
e
s
i
d
u
a
l
 
a
t
 
4
 
 
y
e
a
r
s
B
D
-2 0 2 4
-
2
0
2
4
std.residual at 1  yearsBD
s
t
d
.
r
e
s
i
d
u
a
l
 
a
t
 
5
 
 
y
e
a
r
s
B
D
-2 0 2 4
-
2
0
2
4
std.residual at 1  yearsBD
s
t
d
.
r
e
s
i
d
u
a
l
 
a
t
 
6
 
 
y
e
a
r
s
B
D
-2 0 2 4
-
2
0
2
4
std.residual at 1  yearsBD
s
t
d
.
r
e
s
i
d
u
a
l
 
a
t
 
7
 
 
y
e
a
r
s
B
D
-2 0 2 4
-
2
0
2
4
std.residual at 1  yearsBD
s
t
d
.
r
e
s
i
d
u
a
l
 
a
t
 
8
 
 
y
e
a
r
s
B
D
-2 0 2 4
-
2
0
2
4
 
 
std.residual at 2  yearsBD
s
t
d
.
r
e
s
i
d
u
a
l
 
a
t
 
3
 
 
y
e
a
r
s
B
D
-2 0 2 4
-
2
0
2
4
std.residual at 2  yearsBD
s
t
d
.
r
e
s
i
d
u
a
l
 
a
t
 
4
 
 
y
e
a
r
s
B
D
-2 0 2 4
-
2
0
2
4
std.residual at 2  yearsBD
s
t
d
.
r
e
s
i
d
u
a
l
 
a
t
 
5
 
 
y
e
a
r
s
B
D
-2 0 2 4
-
2
0
2
4
std.residual at 2  yearsBD
s
t
d
.
r
e
s
i
d
u
a
l
 
a
t
 
6
 
 
y
e
a
r
s
B
D
-2 0 2 4
-
2
0
2
4
std.residual at 2  yearsBD
s
t
d
.
r
e
s
i
d
u
a
l
 
a
t
 
7
 
 
y
e
a
r
s
B
D
-2 0 2 4
-
2
0
2
4
std.residual at 2  yearsBD
s
t
d
.
r
e
s
i
d
u
a
l
 
a
t
 
8
 
 
y
e
a
r
s
B
D
-2 0 2 4
-
2
0
2
4
 
 
 
 
std.residual at 3  yearsBD
s
t
d
.
r
e
s
i
d
u
a
l
 
a
t
 
4
 
 
y
e
a
r
s
B
D
-2 0 2 4
-
2
0
2
4
std.residual at 3  yearsBD
s
t
d
.
r
e
s
i
d
u
a
l
 
a
t
 
5
 
 
y
e
a
r
s
B
D
-2 0 2 4
-
2
0
2
4
std.residual at 3  yearsBD
s
t
d
.
r
e
s
i
d
u
a
l
 
a
t
 
6
 
 
y
e
a
r
s
B
D
-2 0 2 4
-
2
0
2
4
std.residual at 3  yearsBD
s
t
d
.
r
e
s
i
d
u
a
l
 
a
t
 
7
 
 
y
e
a
r
s
B
D
-2 0 2 4
-
2
0
2
4
std.residual at 3  yearsBD
s
t
d
.
r
e
s
i
d
u
a
l
 
a
t
 
8
 
 
y
e
a
r
s
B
D
-2 0 2 4
-
2
0
2
4
 
 
 
 
 
 
std.residual at 4  yearsBD
s
t
d
.
r
e
s
i
d
u
a
l
 
a
t
 
5
 
 
y
e
a
r
s
B
D
-2 0 2 4
-
2
0
2
4
std.residual at 4  yearsBD
s
t
d
.
r
e
s
i
d
u
a
l
 
a
t
 
6
 
 
y
e
a
r
s
B
D
-2 0 2 4
-
2
0
2
4
std.residual at 4  yearsBD
s
t
d
.
r
e
s
i
d
u
a
l
 
a
t
 
7
 
 
y
e
a
r
s
B
D
-2 0 2 4
-
2
0
2
4
std.residual at 4  yearsBD
s
t
d
.
r
e
s
i
d
u
a
l
 
a
t
 
8
 
 
y
e
a
r
s
B
D
-2 0 2 4
-
2
0
2
4
Figure 6: QQ-plots of standardized residuals D(Zik) = [Yik − µD(Zik)]/σD(Zik) at different times prior to death for cases.
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Table 1: Estimation based on linear mixed models for CF data.
Fixed effect Random effect
βˆ0 (SE) βˆ1 (SE) βˆ2(SE) βˆ3(SE) σˆint σˆage σˆ †
Control 92.41 (1.46) -1.34(0.06) 38.17 1.34 8.68
Case 43.55 (1.44) -0.62 (0.06) 4.20(0.25) -0.09 (0.01) 25.19 0.93 12.48
†: σˆ is the estimated standard deviation for the residuals.
Table 2: Estimated sensitivities at specificity = 0.9 based on linear mixed models
years relative to death
age threshold 0 1 3 5
age = 10 41.29 0.573 0.511 0.389 0.276
age = 15 39.17 0.603 0.542 0.421 0.306
age = 20 35.25 0.594 0.538 0.424 0.317
Table 3: Estimated sensitivities with 95% confidence interval at specificity = 0.9 based on the semi-
parametric regression quantile method with Epanechnikov’s kernel.
years relative to death
threshold 0 1 3 5
age =10
F0 † 53.33 0.83 (0.81-0.85) 0.77(0.75-0.79) 0.65(0.62-0.68) 0.56(0.53-0.58)
F0(age) ‡ 55.04 0.86(0.80-0.92) 0.81(0.75-0.87) 0.70(0.63-0.77) 0.62(0.52-0.72)
F0(ageBD) † ‡ 53.33 0.87(0.84-0.90) 0.79(0.77-0.81) 0.64(0.61-0.67) 0.50(0.46-0.54)
age =15
F0 40.71 0.74(0.71-0.76) 0.66(0.63-0.68) 0.49(0.46-0.52) 0.36(0.33-0.38)
F0(age) 39.65 0.68(0.60-0.76) 0.60(0.53-0.67) 0.43(0.35-0.51) 0.33(0.25-0.41)
F0(ageBD) 40.71 0.80(0.76-0.84) 0.69(0.66-0.72) 0.50(0.46-0.54) 0.35(0.30-0.40)
age =20
F0 30.69 0.64(0.62-0.67) 0.55(0.52-0.58) 0.38(0.35-0.41) 0.27(0.24-0.30)
F0(age) 27.17 0.55(0.46-0.64) 0.42(0.34-0.50) 0.24(0.16-0.32) 0.15(0.10-0.20)
F0(ageBD) 30.69 0.72(0.68-0.76) 0.57(0.52-0.62) 0.39(0.33-0.45) 0.29(0.24-0.34)
†: F0 does not depend on covariates.
‡: F0 depends on age. Estimated with Epanechnikov’s kernel.
† ‡ : F0 depends on years before death. Estimated with Epanechnikov’s kernel.
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